Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'

Pots of Activia yoghurt, manufactured by Danone SA, sit on display.Bloomberg | Getty ImagesThe CEO of French consumer goods giant Danone downplayed the threat of obesity drugs on its food business, arguing that consumers were likely to turn to healthy products as part of their new weight loss regime.Antoine de Saint-Affrique said that surging demand for drugs like Wegovy and Mounjaro would only increase consumer appetite for more nutritional products."We see ourselves as extremely complementary to GLP-1s," ...